Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.24 USD | -0.58% | -6.02% | -22.03% |
Financials (USD)
Sales 2024 * | 600M | Sales 2025 * | 772M | Capitalization | 5.76B |
---|---|---|---|---|---|
Net income 2024 * | -574M | Net income 2025 * | -517M | EV / Sales 2024 * | 8.65 x |
Net cash position 2024 * | 567M | Net Debt 2025 * | 318M | EV / Sales 2025 * | 7.87 x |
P/E ratio 2024 * |
-10.4
x | P/E ratio 2025 * |
-11.9
x | Employees | 927 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.05% |
Latest transcript on Ionis Pharmaceuticals, Inc.
1 day | -1.72% | ||
1 week | -8.40% | ||
Current month | -4.34% | ||
1 month | -7.84% | ||
3 months | -23.21% | ||
6 months | -16.57% | ||
Current year | -21.98% |
Managers | Title | Age | Since |
---|---|---|---|
D. Walke
FOU | Founder | 58 | 12-06-30 |
Brett Monia
FOU | Founder | 62 | 89-01-09 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 62 | 00-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Loscalzo
CHM | Chairman | 72 | 14-02-02 |
Brett Monia
FOU | Founder | 62 | 89-01-09 |
Joan Herman
BRD | Director/Board Member | 70 | 19-06-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.89% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 39.46 | -0.03% | 58 221 |
24-05-09 | 39.47 | -1.72% | 1,300,598 |
24-05-08 | 40.16 | -1.88% | 1,527,136 |
24-05-07 | 40.93 | -3.19% | 1,211,831 |
24-05-06 | 42.28 | +0.74% | 928,265 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.98% | 5.76B | |
+23.37% | 47.02B | |
+50.13% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- IONS Stock